CXCL12 and digestive system neoplasm: It was demonstrated that the combination of CXCL12 with CXCR4 and CXCR7 on tumor cells leads to antiapoptotic signals upregulated by Bcl‐2 and survivin, and affects the progression of gastrointestinal tumors.34